Canada· CA-DIN-02234470
ATGAM
A antilymphocyte immunoglobulin (horse) product containing lymphocyte immunoglobulin anti-thymocyte globulin (equine), registered in Canada by PFIZER CANADA ULC. The same ATC class is registered in 9 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Antilymphocyte immunoglobulin (horse) is registered in 9 of 19 countries.
Countries holding a registration under ATC L04AA03 (antilymphocyte immunoglobulin (horse)), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Antilymphocyte immunoglobulin (horse) · ATC L04AA03
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- LYMPHOCYTE IMMUNOGLOBULIN ANTI-THYMOCYTE GLOBULIN (EQUINE)
- Manufacturer
- PFIZER CANADA ULC
- Country
- Canada (CA)
- ATC code
- L04AA03
- ATC class
- Antilymphocyte immunoglobulin (horse)
- Defined daily dose
- 1.05 g, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L04AA03
Antilymphocyte immunoglobulin (horse), as other registers publish it.
- DenmarkAtgamPfizer ApS
- SwitzerlandAtgam
- NorwayAtgamPFIZER AS
- FinlandAtgamPfizer Oy
- PolandAtgamPfizer Europe MA EEIG
- BelgiumAtgam 50 mg/mlPfizer
- NetherlandsAtgam 50 mg/ml concentraat voor oplossing voor infusiePfizer B.V.
- IrelandAtgam 50 mg/ml concentrate for solution for infusionPfizer Healthcare Ireland Unlimited Company
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f0482296-d20e-4364-b802-66bd1bbe2bd5 GET /v1/drugs/f0482296-d20e-4364-b802-66bd1bbe2bd5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02234470",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L04AA03",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "55838",
"strengths": [
"50 MG"
],
"ahfs_class": null,
"substances": [
"LYMPHOCYTE IMMUNOGLOBULIN ANTI-THYMOCYTE GLOBULIN (EQUINE)"
],
"product_categorization": null
}See everything about antilymphocyte immunoglobulin (horse).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.